DeepLife develops digital twins of cells for drug discovery. Using AI on multi-omics data, we predict the behaviors of cells when perturbation with drugs, viruses, gene editing, and more. With our unique new generation system biology platform, we help most ambitious organizations discover & prioritize most promising targets and biomarkers to expedite early drug discovery phases.


             For conference production and speaking opportunites:                          For sponsorship and exhibition opportunities: